These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33933251)

  • 1. Predictive Factors for Restenosis Following Stent-Supported Endovascular Therapy with Intravascular Ultrasound Evaluation for Femoropopliteal Chronic Total Occlusion.
    Kurata N; Iida O; Takahara M; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Mano T
    J Vasc Interv Radiol; 2021 May; 32(5):712-720.e1. PubMed ID: 33933251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Characteristics of In-Stent Restenosis After Drug-Eluting Stent Implantation in Femoropopliteal Lesions and 1-Year Prognosis After Repeat Endovascular Therapy for These Lesions.
    Iida O; Takahara M; Soga Y; Hirano K; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2016 Apr; 9(8):828-834. PubMed ID: 27101908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Influencing in-Stent Occlusion after Femoropopliteal Artery Stent Placement with Intravascular Ultrasound Evaluation.
    Kurata N; Iida O; Asai M; Masuda M; Okamoto S; Ishihara T; Nanto K; Mano T
    J Vasc Interv Radiol; 2020 Feb; 31(2):213-220. PubMed ID: 31883937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vessel Calcification as a Risk Factor for In-Stent Restenosis in Complex Femoropopliteal Lesions After Zilver PTX Paclitaxel-Coated Stent Placement.
    Ichihashi S; Shibata T; Fujimura N; Nagatomi S; Yamamoto H; Kyuragi R; Adachi A; Iwakoshi S; Bolstad F; Saeki K; Obayashi K; Kichikawa K
    J Endovasc Ther; 2019 Oct; 26(5):613-620. PubMed ID: 31257994
    [No Abstract]   [Full Text] [Related]  

  • 5. Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.
    Miki K; Fujii K; Tanaka T; Yanaka K; Yoshihara N; Nishimura M; Sumiyoshi A; Horimatsu T; Imanaka T; Fukunaga M; Akahori H; Masuyama T; Ishihara M
    J Endovasc Ther; 2020 Feb; 27(1):77-85. PubMed ID: 31948376
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination therapy of heparin-bonded covered stent and bare-nitinol stent assessed by intravascular ultrasound.
    Katsuki T; Tomoi Y; Yamaji K; Soga Y; Imada K; Ito N; Hiramori S; Ando K
    Heart Vessels; 2020 Nov; 35(11):1502-1509. PubMed ID: 32462463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in Intravascular Ultrasound Measurement Values Between Treatment Modalities for Restenosis in Femoropopliteal Lesions.
    Aihara H; Higashitani M; Takimura H; Tobita K; Jujo K; Hozawa K; Yamaguchi T; Iwata Y; Tokuyama H; Sakurai M; Murata N; Fujimoto Y; Kikuchi A; Koganei H; Sato A; Noguchi Y; Ieda M
    Circ J; 2020 Jul; 84(8):1320-1329. PubMed ID: 32581151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis.
    Tomoi Y; Soga Y; Iida O; Fujihara M; Ando K
    J Endovasc Ther; 2017 Oct; 24(5):640-646. PubMed ID: 28675951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.
    Miki K; Fujii K; Kawasaki D; Shibuya M; Fukunaga M; Imanaka T; Tamaru H; Sumiyoshi A; Nishimura M; Horimatsu T; Saita T; Okada K; Kimura T; Honda Y; Fitzgerald PJ; Masuyama T; Ishihara M
    J Endovasc Ther; 2016 Jun; 23(3):424-32. PubMed ID: 27044270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laser atherectomy and drug-coated balloons for the treatment of femoropopliteal in-stent restenosis: 2-Year outcomes.
    Kokkinidis DG; Behan S; Jawaid O; Hossain P; Giannopoulos S; Singh GD; Laird JR; Valle JA; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):439-446. PubMed ID: 31816169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic characteristics of femoropopliteal in-stent restenosis: association with long-term outcomes after endovascular intervention.
    Armstrong EJ; Singh S; Singh GD; Yeo KK; Ludder S; Westin G; Anderson D; Dawson DL; Pevec WC; Laird JR
    Catheter Cardiovasc Interv; 2013 Dec; 82(7):1168-74. PubMed ID: 23630047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Year Results of the ZEPHYR Registry (Zilver PTX for the Femoral Artery and Proximal Popliteal Artery): Predictors of Restenosis.
    Iida O; Takahara M; Soga Y; Nakano M; Yamauchi Y; Zen K; Kawasaki D; Nanto S; Yokoi H; Uematsu M;
    JACC Cardiovasc Interv; 2015 Jul; 8(8):1105-1112. PubMed ID: 26117463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Polymer-Free Paclitaxel-Eluting Stent Versus a Bare-Metal Stent for De Novo Femoropopliteal Lesions: The BATTLE Trial.
    Gouëffic Y; Sauguet A; Desgranges P; Feugier P; Rosset E; Ducasse E; Kaladji A; Salomon du Mont L; Pernès JM; Commeau P; Lermusiaux P; Leclere B; Guyomarc'h B; Hoffmann CT; Maurel B
    JACC Cardiovasc Interv; 2020 Feb; 13(4):447-457. PubMed ID: 32081238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of intravascular ultrasound in femoropopliteal stenting for peripheral artery disease with TASC II class A to C lesions.
    Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
    J Endovasc Ther; 2014 Aug; 21(4):485-92. PubMed ID: 25101575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser Atherectomy Combined With Drug-Coated Balloon Angioplasty Is Associated With Improved 1-Year Outcomes for Treatment of Femoropopliteal In-Stent Restenosis.
    Kokkinidis DG; Hossain P; Jawaid O; Alvandi B; Foley TR; Singh GD; Waldo SW; Laird JR; Armstrong EJ
    J Endovasc Ther; 2018 Feb; 25(1):81-88. PubMed ID: 29219030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Plaque Calcification and Stent Oversizing on Clinical Outcomes of Atherosclerotic Femoropopliteal Arterial Occlusive Disease Following Stent Angioplasty.
    He HP; Weng JC; Zhao Y; Cai SH; Zhang XL; Yin HH
    Eur J Vasc Endovasc Surg; 2019 Aug; 58(2):215-222. PubMed ID: 30862415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Drug-Eluting Stent Implantation for Femoropopliteal In-Stent Occlusion.
    Tomoi Y; Soga Y; Iida O; Shiraki T; Kobayashi Y; Hiramori S; Ando K
    J Endovasc Ther; 2016 Jun; 23(3):461-7. PubMed ID: 27004496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lumen Gain After Endovascular Therapy in Calcified Superficial Femoral Artery Occlusive Disease Assessed by Intravascular Ultrasound (CODE Study).
    Fujihara M; Kozuki A; Tsubakimoto Y; Takahara M; Shintani Y; Fukunaga M; Iwasaki Y; Nakama T; Yokoi Y
    J Endovasc Ther; 2019 Jun; 26(3):322-330. PubMed ID: 30873909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound guided directional atherectomy versus directional atherectomy guided by angiography for the treatment of femoropopliteal in-stent restenosis.
    Krishnan P; Tarricone A; K-Raman P; Majeed F; Kapur V; Gujja K; Wiley J; Vasquez M; Lascano RA; Quiles KG; Distin T; Fontenelle R; Atallah-Lajam F; Kini A; Sharma S
    Ther Adv Cardiovasc Dis; 2018 Jan; 12(1):17-22. PubMed ID: 29265002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular Management of Femoropopliteal In-Stent Restenosis: A Systematic Review.
    Varela DL; Armstrong EJ
    Cardiovasc Revasc Med; 2019 Oct; 20(10):915-925. PubMed ID: 30447898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.